Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Vaccine-Related Journal Articles

Vaccine Safety: Postlicensure
Archive 2003-1995
Postlicensure 2013
Intradermally-Administered Influenza Virus Vaccine Is Safe and Immunogenic in Healthy Adults 18-64 Years of Age
Authors: Gorse GJ, Falsey AR, Fling JA, Poling TL, Strout CB, Tsang PH
Source: Vaccine, May 1, 2013
Abstract
back to top
Postlicensure 2012
Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy
Authors: Schmader KE, Oxman MN, Levin MJ, et al.
Source: Clin Infect Dis, November 15, 2012, Vol. 55(10):1320-8
Abstract
Measles, Mumps, and Rubella Virus Vaccine (M-M-RII): A Review of 32 Years of Clinical and Postmarketing Experience
Authors: Lievano F, Galea SA, Thornton M, et al.
Source: Vaccine, November 6, 2012, Vol. 30(48):6918-26
Abstract
Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy
Authors: Schmader KE, Oxman MN, Levin MJ, et al.
Source: Clin Infect Dis, November 2012, Vol. 55(10):1320-1328
Abstract
Assessing the Safety of Influenza Immunization during Pregnancy: The Vaccine Safety Datalink
Authors: Kharbanda EO, Vazquez-Benitez G, Shi WX, et al.
Source: Am J Obstet Gynecol, September 2012, Vol. 207(3 Suppl):S47-51
Abstract
Manufacturers' Postmarketing Safety Surveillance of Influenza Vaccine Exposure in Pregnancy
Authors: Khromava A, Cohen CJ, Mazur M, Kanesa-thasan N, Crucitti A, Seifert H
Source: Am J Obstet Gynecol, September 2012, Vol. 207(3 Suppl):S52-6
Abstract
Potential Intussusception Risk versus Benefits of Rotavirus Vaccination in the United States
Authors: Desai R, Cortese MM, Meltzer MI, et al
Source: Pediatr Infect Dis J, August 27, 2012
Abstract
Algorithm to Assess Causality after Individual Adverse Events following Immunizations
Authors: Halsey NA, Edwards KM, Dekker CL, et al.
Source: Vaccine, August 24, 2012, Vol. 30(39):5791-8
Abstract
Assessing the Safety of Influenza Vaccination in Specific Populations: Children and the Elderly
Authors: Rowhani-Rahbar A, Klein NP, Baxter R
Source: Expert Rev Vaccines, August 2012, Vol. 11(8):973-84
Abstract
Guillain-Barre Syndrome During the 2009-2010 H1N1 Influenza Vaccination Campaign: Population-based Surveillance among 45 Million Americans
Authors: Wise ME, Viray M, Sejvar JJ, et al.
Source: Am J Epidemiol, June 1, 2012, Vol. 175(11):1110-9
Abstract
Surveillance for Adverse Events Following Receipt of Pandemic 2009 H1N1 Vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010
Authors: Yih WK, Lee GM, Lieu TA, et al.
Source: Am J Epidemiol, June 1, 2012, Vol. 175(11):1120-8
Abstract
H1N1 Influenza Vaccination during Pregnancy and Fetal and Neonatal Outcomes
Authors: Fell DB, Sprague AE, Liu N, et al.
Source: Am J Public Health, June 2012, Vol. 102(6):e33-40
Abstract
The Combined Measles, Mumps, and Rubella Vaccines and the Total Number of Vaccines Are Not Associated with Development of Autism Spectrum Disorder: The First Case-Control Study in Asia
Authors: Uno Y, Uchiyama T, Kurosawa M, Aleksic B, Ozaki N
Source: Vaccine, e-published April 20, 2012
Abstract
New Framework (GRADE) for Development of Evidence-Based Recommendations by the Advisory Committee on Immunization Practices
Source: MMWR, May 11, 2012, Vol. 61(18):327
HTML
Algorithm to Assess Causality after Individual Adverse Events following Immunizations
Authors: Halsey NA, Edwards KM, Dekker CL, et al
Source: Vaccine, e-published April 13, 2012
Abstract
Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50–59 Years
Authors: Schmader KE, Levin MJ, Gnann JW Jr, et al.
Source: Clin Infect Dis, April 1, 2012, Vol. 54(7):922-8
Abstract
Postlicensure Safety Surveillance for High-Dose Trivalent Inactivated Influenza Vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010
Authors: Moro PL, Arana J, Cano M, et al.
Source: Clin Infect Dis, e-published March 22, 2012
Abstract
Recurrent Guillain-Barrè Syndrome following Vaccination
Authors: Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP; the CISA Network
Source: Clin Infect Dis, March 2012, Vol. 54(6):800-4
Abstract
back to top
Postlicensure 2011
Risk of Disability for US Army Personnel Vaccinated against Anthrax, 1998-2005
Authors: Sulsky SI, Luippold RS, Garman P, Hughes H, Amoroso PJ
Source: Vaccine, August 11, 2011, Vol. 29(35):6035-41
Abstract
Monitoring Vaccine Safety Using the Vaccine Safety Datalink: Utilizing Immunization Registries for Pandemic Influenza
Authors: McCarthy NL, Gee J, Weintraub E, et al.
Source: Vaccine, May 17, 2011
Abstract
Immunization-Safety Monitoring Systems for the 2009 H1N1 Monovalent Influenza Vaccination Program
Authors: Salmon DA, Akhtar A, Mergler MJ, et al.
Source: Pediatrics, May 2011, Vol. 127 Suppl 1:S78-86
Abstract
Food and Drug Administration Regulation and Evaluation of Vaccines
Authors: Marshall V, Baylor NW
Source: Pediatrics, April 18, 2011
Abstract  |  Full article
Ensuring the Optimal Safety of Licensed Vaccines: A Perspective of the Vaccine Research, Development, and Manufacturing Companies
Authors: Kanesa-Thasan N, Shaw A, Stoddard JJ, Vernon TM
Source: Pediatrics, April 18, 2011
Abstract  |  Full article
Statistical, Epidemiological, and Risk-Assessment Approaches to Evaluating Safety of Vaccines throughout the Life Cycle at the Food and Drug Administration
Authors: Ball R, Horne D, Izurieta H, Sutherland A, Walderhaug M, Hsu H
Source: Pediatrics, April 18, 2011
Abstract  |  Full article
Understanding the Role of Human Variation in Vaccine Adverse Events: The Clinical Immunization Safety Assessment Network
Authors: Larussa PS, Edwards KM, Dekker CL, et al.
Source: Pediatrics, April 18, 2011
Abstract  |  Full article
The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety
Authors: Baggs J, Gee J, Lewis E, Fowler G, et al.
Source: Pediatrics, April 18, 2011
Abstract  |  Full article
Tracking Vaccine-Safety Inquiries to Detect Signals and Monitor Public Concerns
Authors: Miller E, Batten B, Hampton L, Campbell SR, Gao J, Iskander J
Source: Pediatrics, April 18, 2011
Abstract  |  Full article
Internet-Based Reporting to the Vaccine Adverse Event Reporting System: A More Timely and Complete Way for Providers to Support Vaccine Safety
Authors: Haber P, Iskander J, Walton K, Campbell SR, Kohl KS
Source: Pediatrics, April 18, 2011
Abstract  |  Full article
Editors' Introduction: Vaccine Safety throughout the Product Life Cycle
Authors: Salmon DA, Pavia A, Gellin B
Source: Pediatrics, April 18, 2011
HTML
Active Surveillance for Adverse Events: The Experience of the Vaccine Safety Datalink Project
Authors: Yih WK, Kulldorff M, Fireman BH, et al.
Source: Pediatrics, April 18, 2011
Abstract  |  Full article
Immunization-Safety Monitoring Systems for the 2009 H1N1 Monovalent Influenza Vaccination Program
Authors: Salmon DA, Akhtar A, Mergler MJ, et al.
Source: Pediatrics, April 18, 2011
Abstract  |  Full article
Intussusception following Rotavirus Vaccine Administration: Post-Marketing Surveillance in the National Immunization Program in Australia
Authors: Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, Booy R, Bines JE; for the PAEDS/APSU Study Group
Source: Vaccine, April 5, 2011, Vol. 29(16):3061-3066
Abstract
Safety of Rotavirus Vaccines: Postmarketing Surveillance in the WHO Region of the Americas
Source: Wkly Epidemiol Rec, February 18, 2011, Vol. 86(8):66-72
PDF
Impact of Rotavirus Vaccination on Hospital-Acquired Rotavirus Gastroenteritis in Children
Authors: Anderson EJ, Rupp A, Shulman ST, Wang D, Zheng X, Noskin GA
Source: Pediatrics, February 2011, Vol. 127(2):e264-70
Abstract
back to top
Postlicensure 2010
Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children: Analysis of the Vaccine Adverse Event Reporting System
Authors: Muhammad RD, Haber P, Broder KR, et al.
Source: Pediatr Infect Dis J, October 29, 2010
Abstract
Guillain-Barrè Syndrome after Gardasil Vaccination: Data from Vaccine Adverse Event Reporting System 2006-2009
Authors: Souayah N, Michas-Martin PA, Nasar A, Krivitskaya N, Yacoub HA, Khan H, Qureshi AI
Source: Vaccine, September 22, 2010
Abstract
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers
Authors: Yeh SH, Gurtman A, Hurley DC, et al.
Source: Pediatrics, August 23, 2010
Abstract
Severe Combined Immunodeficiency (SCID) and Rotavirus Vaccination: Reports to the Vaccine Adverse Events Reporting System (VAERS)
Authors: Bakare N, Menschik D, Tiernan R, Hua W, Martin D
Source: Vaccine, July 30, 2010
Abstract
Multiple Vaccinations and the Risk of Medically Attended Fever
Authors: Lin ND, Kleinman K, Chan KA, et al.
Source: Vaccine, June 7, 2010, Vol. 28(25):4169-74
Abstract
back to top
Postlicensure 2009
Safety of Influenza A (H1N1) 2009 Monovalent Vaccines--United States, October 1-November 24, 2009
Source: MMWR, December 11, 2009, Vol. 58(48):1351-6
HTML
Lack of Association Between Measles-Mumps-Rubella Vaccination and Autism in Children: A Case-Control Study
Authors: Mrożek-Budzyn D, Kiełtyka A, Majewska R
Source: Pediatr Infect Dis J, December 1, 2009
Abstract
Intussusception and Rotavirus Vaccination: A Review of the Available Evidence
Authors: Patel MM, Haber P, Baggs J, Zuber P, Bines JE, Parashar UD
Source: Expert Rev Vaccines, November 2009, Vol. 8(11):1555-64
Abstract
Kawasaki Disease after Vaccination: Reports to the Vaccine Adverse Event Reporting System 1990-2007
Authors: Hua W, Izurieta HS, Slade B, et al.
Source: Pediatr Infect Dis J, November 2009, Vol. 28(11):943-947
Abstract
Death and Serious Illness following Influenza Vaccination: A Multidisciplinary Investigation
Authors: Rue-Cover A, Iskander J, Lyn S, et al.
Source: Pharmacoepidemiol Drug Saf, April 16, 2009
Abstract
Safety of Trivalent Inactivated Influenza Vaccines in Adults: Background for Pandemic Influenza Vaccine Safety Monitoring
Authors: Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P
Source: Vaccine, March 26, 2009, Vol. 27(15):2114-2120
Abstract
Routine Vaccination against Pertussis and the Risk of Childhood Asthma: A Population-Based Cohort Study
Authors: Spycher BD, Silverman M, Egger M, Zwahlen M, Kuehni CE
Source: Pediatrics, March 2009, Vol. 123(3):944-50
Abstract
Varicella Vaccination and Ischemic Stroke in Children: Is There an Association?
Authors: Donahue JG, Kieke BA, Yih WK, et al.
Source: Pediatrics, February 2009, Vol. 123(2):e228-34
Abstract
Vaccines and Guillain-Barre Syndrome
Authors: Haber P, Sejvar J, Mikaeloff Y, Destefano F
Source: Drug Saf, 2009, Vol. 32(4):309-23
Abstract
back to top
Postlicensure 2008
A Distributed Research Network Model for Post-Marketing Safety Studies: The Meningococcal Vaccine Study
Authors: Velentgas P, Bohn RL, Brown JS
Source: Pharmacoepidemiol Drug Saf, December 2008, Vol. 17(12):1226-34
Abstract
A Population-Based, Postlicensure Evaluation of the Safety of a Combination Diphtheria, Tetanus, Acellular Pertussis, Hepatitis B, and Inactivated Poliovirus Vaccine in a Large Managed Care Organization
Authors: Zangwill KM, Eriksen E, Lee M, et al.
Source: Pediatrics, December 2008, Vol. 122(6):e1179-85
Abstract
Guidelines for Collection, Analysis and Presentation of Vaccine Safety Data in Pre- and Post-Licensure Clinical Studies
Authors: Bonhoeffer J, Bentsi-Enchill A, Chen RT, et al.
Source: Vaccine, December 1, 2008
Abstract
Applicability, Reliability, Sensitivity, and Specificity of Six Brighton Collaboration Standardized Case Definitions for Adverse Events following Immunization
Authors: Kohl KS, Magnus M, Ball R, Halsey N, Shadomy S, Farley TA
Source: Vaccine, November 25, 2008, Vol. 26(50):6349-60
Abstract
Adverse Event Reports following Yellow Fever Vaccination
Authors: Lindsey NP, Schroeder BA, Miller ER, et al.
Source: Vaccine, November 11, 2008, Vol. 26(48):6077-82
Abstract
Adverse Events after Anthrax Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007
Authors: Niu MT, Ball R, Woo EJ, Burwen DR, Knippen M, Braun MM; The VAERS Working Group
Source: Vaccine, November 6, 2008 
Abstract
Trends in Intussusception Hospitalizations among US Infants, 1993-2004: Implications for Monitoring the Safety of the New Rotavirus Vaccination Program
Authors: Tate JE, Simonsen L, Viboud C, Steiner C, Patel MM, Curns AT, Parashar UD
Source: Pediatrics, May 2008, Vol. 121(5):e1125-32
Abstract
Elective Termination of Pregnancy after Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006
Authors: Chang S, Ball R, Braun MM
Source: Vaccine, May 2, 2008, Vol. 26(19):2428-32
Abstract
Syncope after Vaccination--United States, January 2005-July 2007
Author: Centers for Disease Control and Prevention
Source: MMWR, May 2, 2008, Vol. 57(17):457-60
HTML
Safety Profile of Pneumococcal Conjugate Vaccines: Systematic Review of Pre- and Post-Licensure Data
Authors: Destefano F, Pfeifer D, Nohynek H
Source: Bull World Health Organ, May 2008, Vol. 86(5):373-80
Abstract
A Process for Sentinel Case Review to Assess Causal Relationships between Smallpox Vaccination and Adverse Outcomes, 2003-2004
Authors: Chapman LE, Iskander JK, Chen RT
Source: Clin Infect Dis, March 15, 2008, Vol. 46 Suppl 3:S271-93
Abstract
Monitoring the Safety of a Smallpox Vaccination Program in the United States: Report of the Joint Smallpox Vaccine Safety Working Group of the Advisory Committee on Immunization Practices and the Armed Forces Epidemiological Board
Authors: Neff J, Modlin J, Birkhead GS, Poland G
Source: Clin Infect Dis, March 15, 2008, Vol. 46 Suppl 3:S258-70
Abstract
A Review of the Smallpox Vaccine Adverse Events Active Surveillance System
Authors: Thomas TN, Reef S, Neff L, Sniadack MM, Mootrey GT
Source: Clin Infect Dis, March 15, 2008, Vol. 46 Suppl 3:S212-20
Abstract
Live Attenuated Measles and Mumps Viral Strain-Containing Vaccines and Hearing Loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990-2003
Authors: Asatryan A, Pool V, Chen RT, Kohl KS, Davis RL, Iskander JK; VAERS team
Source: Vaccine, February 26, 2008, Vol. 26(9):1166-72
Abstract
Inactivated Influenza Vaccine (IIV) in Children <2 Years of Age: Examination of Selected Adverse Events Reported to the Vaccine Adverse Event Reporting System (VAERS) after Thimerosal-Free or Thimerosal-Containing Vaccine
Authors: McMahon AW, Iskander JK, Haber P, Braun MM, Ball R
Source: Vaccine, January 17, 2008, Vol. 26(3):427-9
Abstract
Effects of Stratification on Data Mining in the US Vaccine Adverse Event Reporting System (VAERS)
Authors: Woo EJ, Ball R, Burwen DR, Braun MM
Source: Drug Saf, 2008, Vol. 31(8):667-74
Abstract
back to top
Postlicensure 2007
Diphtheria, Pertussis, Poliomyelitis, Tetanus, and Haemophilus influenzae Type b Vaccinations and Risk of Eczema and Recurrent Wheeze in the First Year of Life
Authors: Kummeling I, Thijs C, Stelma F, et al
Source: Pediatrics, February 2007; 119:367-373
Abstract
Sudden Infant Death Syndrome: No Increased Risk after Immunisation
Authors: Vennemann MM, Butterfass-Bahloul T, Jorch G, et al
Source: Vaccine, January 4, 2007; 25:336-340
Abstract
back to top
Postlicensure 2006
Has the Measles-Mumps-Rubella Vaccine Been Fully Exonerated? (Commentary)
Author: Katz SL
Source: Pediatrics, October 2006, Vol. 118(4):1744-1745
Abstract
No Evidence of Persisting Measles Virus in Peripheral Blood Mononuclear Cells from Children with Autism Spectrum Disorder
Authors: D'Souza Y, Fombonne E, Ward BJ
Source: Pediatrics, October 2006, Vol. 118(4):1664-1675
Abstract
Encephalopathy after Whole-Cell Pertussis or Measles Vaccination: Lack of Evidence for a Causal Association in a Retrospective Case-Control Study
Authors: Ray P, Hayward J, Michelson D, et al
Source: Pediatr Infect Dis J, September 2006, Vol. 25(9):768-773
Abstract
Pervasive Developmental Disorders in Montreal, Quebec, Canada: Prevalence and Links with Immunizations
Authors: Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D
Source: Pediatrics, July 2006, Vol. 118(1):e139-e150
Abstract
Solicited Adverse Events after Influenza Immunization among Infants, Toddlers, and Their Household Contacts
Authors: Skowronski DM, Jacobsen K, Daigneault J, et al
Source: Pediatrics, June 2006, Vol. 117:1963-1971
Abstract
Vaccine Adverse Event Reporting System Reporting Source: A Possible Source of Bias in Longitudinal Studies
Authors: Goodman MJ, Nordin J
Source: Pediatrics, February 2006, Vol. 117(2):387-390
Abstract
back to top
Postlicensure 2005
Vaccine Safety Controversies and the Future of Vaccination Programs
Authors: Francois G, Duclos P, Margolis H, et al
Source: Pediatr Infect Dis J, Nov. 2005, Vol. 24(11):953-961
Abstract
Vaccine Safety Research, Data Access, and Public Trust
Authors: Committee on the Review of the National Immunization Program's Research Procedures and Data Sharing Program
Source: National Academies Press, February 2005
HTML
back to top
Postlicensure 2004
The Role of the Vaccine Adverse Event Reporting System (VAERS) in Monitoring Vaccine Safety
Authors: Iskander JK, Miller ER, Chen RT
Source: Pediatric Annals, September 2004, Vol. 33(9):599-606
Abstract
Notice to Readers: Public Comment Sought on CDC's Vaccine Safety
Source: MMWR, August 13, 2004, Vol. 53(31):720
HTML
MMR Vaccination and Febrile Seizures
Authors: Vestergaard M, Hviid A, Meldgaard Madsen K, et al.
Source: JAMA, July 21, 2004, Vol. 292(3):351-7
Abstract
Vaccine Risk Perception Among Reporters of Autism after Vaccination: Vaccine Adverse Event Reporting System 1990-2001
Authors: Woo EJ, Ball R, Bostrom A, et al.
Source: American Journal of Public Health
Abstract
Understanding Vaccine Safety Information from the Vaccine Adverse Reporting System
Authors: Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT
Source: Pediatric Infectious Diseases Journal, April 2004, Vol. 23(4):287-294
Abstract
Adverse Events after Immunisation with Aluminum-Containing DTP Vaccines: Systematic Review of the Evidence
Authors: Jefferson T, Rudin M, Di Pietrantonj C
Source: The Lancet: Infectious Diseases, February 1, 2004, Vol. 4(2):84-90
Abstract
back to top
Postlicensure Archive
Postlicensure journal articles
Immunization Action Coalition  •  1573 Selby Ave  •  St. Paul, MN 55104
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.